Skip Ribbon Commands
Skip to main content
Sign In

23198 Drug of Abuse Survey With Confirmation - Mini, Urine

Drug of Abuse Survey With Confirmation - Mini, Urine
Test Code: MINDAS
Synonyms/Keywords
​Amphetamines, Cannabinoids, Cocaine, Opiates, Oxycodone, Marijuana, THC, Benzoylecgonine, Hydromorphone, Hydrocodone, Morphine, Codeine, Oxycontin, Vicodin, Amines
Test Components
Immunoassay screen plus mass-spectrometry method confirmation (when needed) for the following drug classes or method groups:  amphetamines, cannabinoids, cocaine metabolite, opiate method group, and oxycodone method group.  Test also includes specimen validity testing (creatinine, pH, and oxidants) to detect adulteration, dilution, or substitution of the specimen.​
Useful For
​The detection of drug classes listed in this survey is useful for compliance monitoring and identification of abuse. 
Specimen Requirements
Fasting Required Specimen Type Preferred Container/Tube Acceptable Container/Tube Specimen Volume Specimen Minimum Volume
(allows for 1 repeat)
Pediatric Minimum Volume
(no repeat)
No​ Urine​ Sage urine collection container​ Sterile plastic container with no preservatives​ 10 mL​ 8 mL​ 5 mL​
Specimen Stability Information
Specimen Type Temperature Time
Urine​ Refrigerate (Preferred)​ 30 days​
Ambient​ 7 days​
Frozen​ 30 days​
Performing Laboratory Information
Performing Location Day(s) Test Performed Analytical Time Methodology/Instrumentation
Marshfield​ Monday through Friday​
If no confirmatory work is required: 1 day​
 
If confirmatory work is required: 4 days
Beckman AU680 Clinical Chemistry System with Emit Immunoassay and Gas Chromatography-Mass Spectrometry (GCMS) using Selected Ion Monitoring and/or Liquid Chromatography/Tandem Mass Spectrometry (LCMS/MS) using Multiple Reaction Monitoring (if needed for confirmation)​
Test Information
This test was developed and its performance characteristics determined by Marshfield Labs. This laboratory is certified under the Clinical Laboratory Improvement Amendments (CLIA) to perform high complexity testing.
 
This test is designed to support medical, not forensic, purposes. The detection of drugs listed in this survey is to be used for compliance monitoring and identification of abuse.
 
This test uses immunoassy methods to first screen for the following drug classes or method groups: amphetamines, cannabinoids, cocaine, opiate method group, and oxycodone method group, at and above cut-off levels. If the screen is positive, this test also includes mass-spectrometry method confirmation.  Test also includes specimen validity testing (creatinine, pH, and oxidants) to detect adulteration, dilution, or substitution of the specimen.
 
All confirmations / quantitations are charged separately as needed.
 
The amphetamine class includes phentermine, amphetamine, methamphetamine, ephedrine, pseudoephedrine, MDA, MDEA, and MDMA (Ecstasy).
 
Opiate method group includes morphine, codeine, hydrocodone, hydromorphone.
 
Oxycodone method group includes oxycodone and oxymorphone.​
Reference Range Information
Performing Location Reference Range
​Marshfield Negative.  Positives are reported with a quantitative mass-spectrometry method result.​
Interpretation

Current Cutoff Levels for Toxicology

For detailed interpretation information of each drug class/group, please refer to the individual test codes.​

Outreach CPTs
CPT Modifier
(if needed)
Quantity Description Comments
80307​ 1 Single Drug Class Screen​
80359​ ​1 ​Methylenedioxyamphetamines (MDA, MDMA) ​If needed
80326​ 1​ Amphetamines confirmation ​If needed
​G0480 ​1 ​Amphetamines confirmation ​For Medicare/Medicaid (if needed)
80349​ 1​ Cannabinoids confirmation ​​If needed
​G0480 ​1 ​Cannabinoids confirmation ​​For Medicare/Medicaid (if needed)
80353​ 1​ Cocaine confirmation ​​If needed
​G0480 ​1 ​Cocaine confirmation ​​For Medicare/Medicaid (if needed)
80361​ 1​ Opiate confirmation ​​If needed
G0480​ ​1 ​Opiate confirmation ​​For Medicare/Medicaid (if needed)
80365​ 1​ Oxycodone confirmation ​​If needed
​G0480 ​1 ​Oxycodone confirmation ​​For Medicare/Medicaid (if needed)
Classification
This test was developed and its performance characteristics determined by Marshfield Labs. This laboratory is certified under the Clinical Laboratory Improvement Amendments (CLIA) to perform high complexity testing.
Synonyms/Keywords
​Amphetamines, Cannabinoids, Cocaine, Opiates, Oxycodone, Marijuana, THC, Benzoylecgonine, Hydromorphone, Hydrocodone, Morphine, Codeine, Oxycontin, Vicodin, Amines
Test Components
Immunoassay screen plus mass-spectrometry method confirmation (when needed) for the following drug classes or method groups:  amphetamines, cannabinoids, cocaine metabolite, opiate method group, and oxycodone method group.  Test also includes specimen validity testing (creatinine, pH, and oxidants) to detect adulteration, dilution, or substitution of the specimen.​
Ordering Applications
Ordering Application Description
​Centricity ​Drug of Abuse Survey-Mini
​Cerner ​Drug of Abuse Survey-Mini
​COM ​DAU Mini Survey with Confirm
If the ordering application you are looking for is not listed, contact your local laboratory for assistance.
Specimen Requirements
Fasting Required Specimen Type Preferred Container/Tube Acceptable Container/Tube Specimen Volume Specimen Minimum Volume
(allows for 1 repeat)
Pediatric Minimum Volume
(no repeat)
No​ Urine​ Sage urine collection container​ Sterile plastic container with no preservatives​ 10 mL​ 8 mL​ 5 mL​
Specimen Stability Information
Specimen Type Temperature Time
Urine​ Refrigerate (Preferred)​ 30 days​
Ambient​ 7 days​
Frozen​ 30 days​
Useful For
​The detection of drug classes listed in this survey is useful for compliance monitoring and identification of abuse. 
Test Components
Immunoassay screen plus mass-spectrometry method confirmation (when needed) for the following drug classes or method groups:  amphetamines, cannabinoids, cocaine metabolite, opiate method group, and oxycodone method group.  Test also includes specimen validity testing (creatinine, pH, and oxidants) to detect adulteration, dilution, or substitution of the specimen.​
Reference Range Information
Performing Location Reference Range
​Marshfield Negative.  Positives are reported with a quantitative mass-spectrometry method result.​
Interpretation

Current Cutoff Levels for Toxicology

For detailed interpretation information of each drug class/group, please refer to the individual test codes.​

For more information visit:
Performing Laboratory Information
Performing Location Day(s) Test Performed Analytical Time Methodology/Instrumentation
Marshfield​ Monday through Friday​
If no confirmatory work is required: 1 day​
 
If confirmatory work is required: 4 days
Beckman AU680 Clinical Chemistry System with Emit Immunoassay and Gas Chromatography-Mass Spectrometry (GCMS) using Selected Ion Monitoring and/or Liquid Chromatography/Tandem Mass Spectrometry (LCMS/MS) using Multiple Reaction Monitoring (if needed for confirmation)​
For billing questions, see Contacts
Outreach CPTs
CPT Modifier
(if needed)
Quantity Description Comments
80307​ 1 Single Drug Class Screen​
80359​ ​1 ​Methylenedioxyamphetamines (MDA, MDMA) ​If needed
80326​ 1​ Amphetamines confirmation ​If needed
​G0480 ​1 ​Amphetamines confirmation ​For Medicare/Medicaid (if needed)
80349​ 1​ Cannabinoids confirmation ​​If needed
​G0480 ​1 ​Cannabinoids confirmation ​​For Medicare/Medicaid (if needed)
80353​ 1​ Cocaine confirmation ​​If needed
​G0480 ​1 ​Cocaine confirmation ​​For Medicare/Medicaid (if needed)
80361​ 1​ Opiate confirmation ​​If needed
G0480​ ​1 ​Opiate confirmation ​​For Medicare/Medicaid (if needed)
80365​ 1​ Oxycodone confirmation ​​If needed
​G0480 ​1 ​Oxycodone confirmation ​​For Medicare/Medicaid (if needed)
Classification
This test was developed and its performance characteristics determined by Marshfield Labs. This laboratory is certified under the Clinical Laboratory Improvement Amendments (CLIA) to perform high complexity testing.
For most current information refer to the Marshfield Laboratory online reference manual.